|3Jul 24, 5:16 PM ET

BAYER AKTIENGESELLSCHAFT 3

3 · Azitra Inc · Filed Jul 24, 2023

Insider Transaction Report

Form 3
Period: 2023-06-15
Holdings
  • Series B Convertible Preferred Stock

    Common Stock (1,307,401 underlying)
Footnotes (3)
  • [F1]Each share of Series B Convertible Preferred Stock will automatically convert into one share of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date.
  • [F2]The number of shares represented reflects a forward stock split at a ratio of 7.1-for-1 which was effectuated upon the effectiveness of the Issuer's Form S-1 (File No. 333-269876).
  • [F3]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT